Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 27, 2014
Patent Application Number
13212101
Date Filed
August 17, 2011
Patent Citations Received
Patent Primary Examiner
Patent abstract
Modified relaxin polypeptides and their uses are provided. In one aspect, the disclosure provides a relaxin polypeptide comprising one or more non-naturally encoded amino acids. The polypeptide may be linked to a linker, polymer, or biologically active molecule. The serum half-life of the relaxin polypeptide may be enhanced relative to the unconjugated form. In another aspect, the disclosure provides methods of treating a patient having a disorder modulated by relaxin.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.